Planar Imaging Protocol. All sympathomimetic medicines that could potentially interfere with
the uptake ofMIBG were discontin ued for at least 5 half-lives before the scintigraphic …

Carvedilol and metoprolol have been reported to be effective in the treatment of patients with
chronic heart failure. However, to our knowledge, there have been no studies comparing the …

Background Carvedilol treatment reduces the mortality rate in patients with congestive heart
failure. It is not known whether carvedilol treatment is effective in heart failure patients with …

In chronic heart failure, elevated plasma norepinephrine (NE) levels and a disparity between
the neuronal release and the effective reuptake of NE lead to an increased concentration of …

Background. We examined whether cardiac sympathetic imaging with iodine-123
metaiodobenzylguanidine (MIBG) would predict improvement of left ventricular (LV) function …

Background Patients with heart failure show signs of cardiac sympathetic dysfunction such
as elevation of blood norepinephrine (NE) level, as a result of reduction in the number of …

Objective To investigate the value of iodine-123 meta-iodobenzylguanidine (MIBG)
myocardial imaging for defining high risk patients with idiopathic dilated cardiomyopathy …

It is crucial to predict drug effectiveness in chronic disease, such as dilated cardiomyopathy
(DCM), in which the left ventricular (LV) function might be improved by β-blocker therapy. As …

[1@ I] MlBGwas performedinpatientswithidiopathiccongestive cardiomyopathyand
compared to normal controls. Initialuptake, half-time of tracer within the heart, and heart to …

Carvedilol is a β-blocking agent with antioxidant properties that has been shown to improve
survival in chronic heart failure (CHF). Previous open-label studies have suggested that its …